Life Sciences AI Technology Performance Benchmark
Analysis based on 6 articles · First reported Aug 10, 2026 · Last updated Aug 10, 2026
The benchmark provides market intelligence that may influence vendor selection and investment decisions in the life sciences AI sector. Recognition as a category leader could enhance the market position and perceived credibility of the named companies, potentially affecting their commercial prospects.
Black Book Research, in partnership with Applied Artificial Intelligence LLC, published the 2026-2027 Life Sciences AI Technology Performance Benchmark on August 10, 2026. The independent study, based on feedback from 1,277 verified buyers and users, evaluated 254 market participants across 28 categories spanning the molecule-to-market lifecycle. The benchmark identifies client-rated technology leaders in areas such as target discovery, clinical development, real-world evidence, manufacturing, and enterprise AI governance. Key findings indicate that life sciences buyers are moving beyond model novelty toward governed production, expecting AI systems to operate within validated workflows, maintain data lineage, and support human oversight. The report highlights category leaders including Insilico Medicine, Schrödinger, Tempus AI, Medidata, Veeva Systems, Siemens, and others. The research underscores a shift toward AI investment in evidence generation, clinical operations, AI-ready data foundations, regulated manufacturing, and enterprise AI governance.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard